Retraction: Receptor Tyrosine Kinase AXL is Correlated with Poor Prognosis and Induces Temozolomide Resistance in Glioblastoma.

Jia Wang,Jie Zuo,Mao-De Wang,Wan-Fu Xie,Xiao-Bin Bai,Xu-Dong Ma
DOI: https://doi.org/10.1111/cns.13227
2019-01-01
CNS Neuroscience & Therapeutics
Abstract:Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.
What problem does this paper attempt to address?